tert-Butyl 4-(bromomethyl)-3,5-difluorobenzoate

Catalog No.: 
ACEVOX395
CAS No.: 
1363405-79-1
Molecular Formula: 
C12H13BrF2O2
Molecular Weight: 
307.13
tert-Butyl 4-(bromomethyl)-3,5-difluorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$266.00InquiryInquiry
250mg97%$467.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(bromomethyl)-3,5-difluorobenzoate
IUPAC Nametert-butyl 4-(bromomethyl)-3,5-difluorobenzoate
MDL No.MFCD21607424
Molecular FormulaC12H13BrF2O2
Molecular Weight307.13
SMILESO=C(OC(C)(C)C)C1=CC(F)=C(CBr)C(F)=C1
InChI KeyXAXWKQQZYBKNKD-UHFFFAOYSA-N
Synonymtert-Butyl 4-(bromomethyl)-3,5-difluorobenzoate;Benzoic acid, 4-(bromomethyl)-3,5-difluoro-, 1,1-dimethylethyl ester
CAS No.1363405-79-1

Safety Data

Pictogram
Harmful or irritantCorrosive
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACEVOX395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEVOX395 route product structure diagram
    ACEVOX3951363405-79-1
Inquiry

2. ACEVOX395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEVOX395 route product structure diagram
    ACEVOX3951363405-79-1
Inquiry

3. ACEVOX395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEVOX395 route product structure diagram
    ACEVOX3951363405-79-1
Inquiry

Comments (0)